Cureton Kevin 4
4 · NANOPHASE TECHNOLOGIES Corp · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Cureton Kevin
VP Sales & Mktg & Bus Dev
Transactions
- Award
Common Stock (right to purchase)
2024-12-31$2.44/sh+22,500$54,900→ 22,500 totalExercise: $2.44From: 2025-12-31Exp: 2031-12-31→ Common Stock (22,500 underlying)
Holdings
- 192,212
Common Stock
- 80,000
Common Stock (right to purchase)
Exercise: $0.82From: 2019-05-23Exp: 2028-05-23→ Common Stock (80,000 underlying) - 16,500
Common Stock (right to purchase)
Exercise: $0.51From: 2020-05-22Exp: 2029-05-22→ Common Stock (16,500 underlying) - 12,600
Common Stock (right to purchase)
Exercise: $0.61From: 2024-12-27Exp: 2030-12-27→ Common Stock (12,600 underlying) - 50,000
Common Stock (right to purchase)
Exercise: $0.68From: 2018-02-21Exp: 2027-02-21→ Common Stock (50,000 underlying) - 43,500
Common Stock (right to purchase)
Exercise: $0.42From: 2017-02-23Exp: 2026-02-23→ Common Stock (43,500 underlying) - 90,000
Common Stock (right to purchase)
Exercise: $4.17From: 2022-12-28Exp: 2028-12-28→ Common Stock (90,000 underlying) - 72,000
Common Stock (right to purchase)
Exercise: $1.17From: 2023-12-20Exp: 2029-12-20→ Common Stock (72,000 underlying) - 90,000
Common Stock (right to purchase)
Exercise: $0.45From: 2021-06-18Exp: 2027-06-18→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.